drugset / Trial / NCT00003489
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
NaSingle-groupOpen-labelTreatment
Summary
Current therapies for advanced Head and Neck Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of advanced Head and Neck Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with advanced Head and Neck Cancer.
Timeline
- Start
- 1996-05-06
- Primary completion
- 1998-04-03
- Completion
- 1998-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Astugenal | Unknown | — | Intravenous |
| Subject | antineoplaston A10 | Small molecule | — | Intravenous |